0001127602-24-003099.txt : 20240202
0001127602-24-003099.hdr.sgml : 20240202
20240202160751
ACCESSION NUMBER: 0001127602-24-003099
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240202
FILED AS OF DATE: 20240202
DATE AS OF CHANGE: 20240202
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: MIZELL STEVEN
CENTRAL INDEX KEY: 0001189403
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-06571
FILM NUMBER: 24591427
MAIL ADDRESS:
STREET 1: 2000 GALLOPING HILL ROAD
CITY: KENILWORTH
STATE: NJ
ZIP: 07033
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Merck & Co., Inc.
CENTRAL INDEX KEY: 0000310158
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 221918501
STATE OF INCORPORATION: NJ
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2000 GALLOPING HILL ROAD
CITY: KENILWORTH
STATE: NJ
ZIP: 07033
BUSINESS PHONE: 908-740-4000
MAIL ADDRESS:
STREET 1: 2000 GALLOPING HILL ROAD
CITY: KENILWORTH
STATE: NJ
ZIP: 07033
FORMER COMPANY:
FORMER CONFORMED NAME: Merck & Co. Inc.
DATE OF NAME CHANGE: 20091103
FORMER COMPANY:
FORMER CONFORMED NAME: SCHERING PLOUGH CORP
DATE OF NAME CHANGE: 19920703
4
1
form4.xml
PRIMARY DOCUMENT
X0508
4
2024-02-02
0000310158
Merck & Co., Inc.
MRK
0001189403
MIZELL STEVEN
MERCK & CO., INC.
126 EAST LINCOLN AVENUE
RAHWAY
NJ
07065
1
EVP, Chief HR Officer
0
Common Stock
2024-02-02
4
M
0
824
70.71
A
42143.145
D
Common Stock
2024-02-02
4
M
0
32170
73.73
A
74313.145
D
Common Stock
2024-02-02
4
S
0
50694
126.6491
D
23619.145
D
Stock Option (Right to Buy)
70.71
2024-02-02
4
M
0
824
0
D
2019-10-30
2028-10-29
Common Stock
824
0
D
Stock Option (Right to Buy)
73.73
2024-02-02
4
M
0
32170
0
D
2022-05-04
2031-05-03
Common Stock
32170
22088
D
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $126.4300 to $126.9000, inclusive. The reporting person undertakes to provide to Merck & Co., Inc., any security holder of Merck & Co., Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The option vested and became exercisable in three equal installments on 10/30/2019, 10/30/2020 and 10/30/2021.
The option vests and becomes exercisable in three equal installments on 5/4/2022, 5/4/2023 and 5/4/2024.
/s/ Kelly E. W. Grez as Attorney-in-Fact for Steven C. Mizell
2024-02-02